首页 | 本学科首页   官方微博 | 高级检索  
     

术中应用丝裂霉素C预防翼状胬肉术后复发的疗效观察
引用本文:谢青,莫杏君,蒋幼芹. 术中应用丝裂霉素C预防翼状胬肉术后复发的疗效观察[J]. 中南大学学报(医学版), 2001, 26(4): 347-349
作者姓名:谢青  莫杏君  蒋幼芹
作者单位:中南大学湘雅二医院眼科;中南大学湘雅二医院眼科;中南大学湘雅二医院眼科
摘    要:目的 :探讨丝裂霉素 (mitomycinC ,MMC)在翼状胬肉转移术中的应用及与MMC接触的眼表组织超微结构改变。方法 :将 5 7例 (6 2只眼 )原发性进行期翼状胬肉随机分为对照组和MMC组 ,对照组 2 8例 (30只眼 ) ,MMC组2 9例 (32只眼 )。对照组行单纯翼状胬肉转移术 ,MMC组术中局部放置饱含 0 4mg·ml-1MMC的棉片 1min。比较两组复发率及术后并发症。电镜观察并比较接触及未与MMC接触的眼表组织的超微结构。术后随访 (7 6± 3 4)月 (1~13个月 )。结果 :MMC组 2只眼 (6 3% )复发 ,对照组 11只眼 (36 7% )复发 (P <0 0 0 5 ) ,随访期间未见严重并发症。电镜观察到与MMC接触的眼表组织显示大多数纤维母细胞 (fibroblast,FB)的粗面内质网 (roughendoplasmicreticulum ,RER)扩张 ,其他细胞无明显改变 ,对照组无此改变。结论 :原发性翼状胬肉转移术中局部应用 0 4mg·ml-1MMC 1min ,是一种防止术后复发的安全、有效而又简单的方法。眼表组织接触 0 4mg·ml-1MMC 1min后 ,FB显示RER扩张。

关 键 词:丝裂霉素C  翼状胬肉*  超微结构  治疗应用  眼疾病
文章编号:1000-5625(2001)04-0347-03
修稿时间:2000-11-23

Study of intraoperative mitomycin C in preventing recurrence after pterygium surgery
XIE Qing,MO Xing jun,JIANG You qin. Study of intraoperative mitomycin C in preventing recurrence after pterygium surgery[J]. Journal of Central South University. Medical sciences, 2001, 26(4): 347-349
Authors:XIE Qing  MO Xing jun  JIANG You qin
Affiliation:(Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha 410011, China)
Abstract:Objective To explore the feasibility of intraoperative application of mitomycin C (MMC) in pterygium and observe the ultrastructure change of pterygium with or without intraoperative application of MMC. Methods Sixty two eyes of 57 patients with primary pterygium were randomly divided into MMC group and control group, 29 patients (32 eyes) in MMC group underwent transposition with intraoperative application of MMC (0 4?mg·ml -1 for 1 minute), whereas 28 patients (30 eyes) in control group underwent transposition. The recurrence rate, complications and side effects were observed and compared between the two groups. The ultrastructure of pterygium with or without intraoperative application of MMC was studied with transmission electron microscopy. The mean follow up was(7 6±3 4)months (1~13 minths). Result Eleven eyes of the 30 eyes in control group (36 %)showed recurrence, whereas only 2 of 32 eyes (6 3%)in MMC group showed recurrence (P<0 005). No severe complication and side effect appeared during the follow up. Most of fibroblasts in pterygium that underwent intraoperative MMC occured the change of rough endoplasmic reticulum (RER) dilatation. Conclusion Intraoperative MMC appears to be an effective treatment in preventing recurrence of primary pterygium. The fibroblasts in pterygium have RER dilatation after application of MMC for 1 minute during the operation.
Keywords:mitomycin C pterygium  ultrastructure  therapeutic use  eye diseases
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中南大学学报(医学版)》浏览原始摘要信息
点击此处可从《中南大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号